
John A. Ward
Examiner (ID: 10393)
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2885, 2875 |
| Total Applications | 1293 |
| Issued Applications | 1015 |
| Pending Applications | 41 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 827063
[patent_doc_number] => 07402729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission'
[patent_app_type] => utility
[patent_app_number] => 11/151227
[patent_app_country] => US
[patent_app_date] => 2005-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15105
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402729.pdf
[firstpage_image] =>[orig_patent_app_number] => 11151227
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/151227 | Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission | Jun 13, 2005 | Issued |
Array
(
[id] => 4802596
[patent_doc_number] => 20080014183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Anticancer Agent Containing Dendritic Cell Having Rna Virus Transferred Thereinto'
[patent_app_type] => utility
[patent_app_number] => 11/630532
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 17547
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014183.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630532 | Anticancer agent containing dendritic cell having RNA virus transferred thereinto | Apr 27, 2005 | Issued |
Array
(
[id] => 6966010
[patent_doc_number] => 20050232907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Use of herpes vectors for tumor therapy'
[patent_app_type] => utility
[patent_app_number] => 11/097391
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9447
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097391 | Use of herpes vectors for tumor therapy | Apr 3, 2005 | Abandoned |
Array
(
[id] => 7004587
[patent_doc_number] => 20050169900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Allogeneic vaccine and methods to synthesize same'
[patent_app_type] => utility
[patent_app_number] => 11/096041
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 41465
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169900.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096041
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096041 | Allogeneic vaccine and methods to synthesize same | Mar 30, 2005 | Abandoned |
Array
(
[id] => 4739987
[patent_doc_number] => 20080233640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Prostate Stem Cell'
[patent_app_type] => utility
[patent_app_number] => 10/593128
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6580
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593128
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593128 | Prostate stem cell | Mar 17, 2005 | Issued |
Array
(
[id] => 6963061
[patent_doc_number] => 20050216964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Swine defective for transmission of porcine endogenous retrovirus and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/077996
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8917
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20050216964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11077996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/077996 | Swine defective for transmission of porcine endogenous retrovirus and uses thereof | Mar 10, 2005 | Abandoned |
Array
(
[id] => 7168234
[patent_doc_number] => 20050201985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Modified adenoviral vectors for use in vaccines and gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/064910
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11981
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201985.pdf
[firstpage_image] =>[orig_patent_app_number] => 11064910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/064910 | Modified adenoviral vectors for use in vaccines and gene therapy | Feb 23, 2005 | Abandoned |
Array
(
[id] => 5621491
[patent_doc_number] => 20060191026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Tissue specific expression of antibodies in chickens'
[patent_app_type] => utility
[patent_app_number] => 11/062325
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15986
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20060191026.pdf
[firstpage_image] =>[orig_patent_app_number] => 11062325
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/062325 | Tissue specific expression of antibodies in chickens | Feb 17, 2005 | Abandoned |
Array
(
[id] => 7168066
[patent_doc_number] => 20050201936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Models for viral-based cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/057710
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 26621
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201936.pdf
[firstpage_image] =>[orig_patent_app_number] => 11057710
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/057710 | Models for viral-based cancer therapy | Feb 13, 2005 | Abandoned |
Array
(
[id] => 7045116
[patent_doc_number] => 20050249711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Allogeneic vaccine and methods to synthesize same'
[patent_app_type] => utility
[patent_app_number] => 11/054300
[patent_app_country] => US
[patent_app_date] => 2005-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 41447
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249711.pdf
[firstpage_image] =>[orig_patent_app_number] => 11054300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/054300 | Allogeneic vaccine and methods to synthesize same | Feb 6, 2005 | Abandoned |
Array
(
[id] => 5767893
[patent_doc_number] => 20060019387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Liver stem cell'
[patent_app_type] => utility
[patent_app_number] => 11/039119
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4776
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019387.pdf
[firstpage_image] =>[orig_patent_app_number] => 11039119
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/039119 | Liver stem cell | Jan 18, 2005 | Issued |
Array
(
[id] => 7005732
[patent_doc_number] => 20050171045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses'
[patent_app_type] => utility
[patent_app_number] => 11/025796
[patent_app_country] => US
[patent_app_date] => 2004-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26866
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171045.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025796 | Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses | Dec 28, 2004 | Abandoned |
Array
(
[id] => 4652153
[patent_doc_number] => 20080039409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Method of Suppressing Cancer'
[patent_app_type] => utility
[patent_app_number] => 10/584289
[patent_app_country] => US
[patent_app_date] => 2004-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7522
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584289
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584289 | Method of Suppressing Cancer | Dec 23, 2004 | Abandoned |
Array
(
[id] => 5535579
[patent_doc_number] => 20090235367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof'
[patent_app_type] => utility
[patent_app_number] => 10/585077
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12019
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20090235367.pdf
[firstpage_image] =>[orig_patent_app_number] => 10585077
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585077 | Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof | Dec 21, 2004 | Abandoned |
Array
(
[id] => 7252969
[patent_doc_number] => 20050142659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Purified populations of stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/015067
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9137
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142659.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015067
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015067 | Purified populations of stem cells | Dec 15, 2004 | Abandoned |
Array
(
[id] => 5795268
[patent_doc_number] => 20060015949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Transgenic non-human animals for producing heterologous and chimeric antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/009840
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 102
[patent_figures_cnt] => 102
[patent_no_of_words] => 89179
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20060015949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009840
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009840 | Transgenic non-human animals for producing heterologous and chimeric antibodies | Dec 9, 2004 | Abandoned |
Array
(
[id] => 5795276
[patent_doc_number] => 20060015957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Transgenic non-human animals for producing chimeric antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/009873
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 102
[patent_figures_cnt] => 102
[patent_no_of_words] => 89232
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20060015957.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009873 | Transgenic non-human animals for producing chimeric antibodies | Dec 9, 2004 | Issued |
Array
(
[id] => 5822390
[patent_doc_number] => 20060026703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Transgenic non-human animals for producing heterologous and chimeric antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/009769
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 102
[patent_figures_cnt] => 102
[patent_no_of_words] => 89236
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20060026703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11009769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/009769 | Transgenic non-human animals for producing heterologous and chimeric antibodies | Dec 9, 2004 | Abandoned |
Array
(
[id] => 7503587
[patent_doc_number] => 08034790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-11
[patent_title] => 'Use of MDA-7 to inhibit pathogenic infectious organisms'
[patent_app_type] => utility
[patent_app_number] => 11/001702
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 29995
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/034/08034790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001702
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001702 | Use of MDA-7 to inhibit pathogenic infectious organisms | Nov 30, 2004 | Issued |
Array
(
[id] => 5085390
[patent_doc_number] => 20070275441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Ocular Tissue Modification'
[patent_app_type] => utility
[patent_app_number] => 10/579995
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12566
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275441.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579995
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579995 | Ocular Tissue Modification | Nov 18, 2004 | Abandoned |